1. Home
  2. LGIH vs NEO Comparison

LGIH vs NEO Comparison

Compare LGIH & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$46.28

Market Cap

1.1B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
NEO
Founded
2003
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2013
2008

Fundamental Metrics

Financial Performance
Metric
LGIH
NEO
Price
$46.28
$9.24
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$75.90
$13.38
AVG Volume (30 Days)
409.4K
2.0M
Earning Date
04-28-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$1,705,504,000.00
N/A
Revenue This Year
$2.32
$10.63
Revenue Next Year
$17.94
$9.73
P/E Ratio
$515.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$4.72
52 Week High
$69.42
$13.74

Technical Indicators

Market Signals
Indicator
LGIH
NEO
Relative Strength Index (RSI) 55.32 60.46
Support Level $45.69 $7.42
Resistance Level $49.51 $10.82
Average True Range (ATR) 2.26 0.40
MACD -0.14 0.04
Stochastic Oscillator 75.68 89.45

Price Performance

Historical Comparison
LGIH
NEO

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: